Acepodia Biotech Inc.   Report issue

For profit Phase 1
Founded: San Mateo CA United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04319757
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Acepodia Biotech Inc. | Acepodia Biotech, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Stomach Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 5